Trials / Completed
CompletedNCT01264016
Performance of a New Glucose Meter System
Performance of the TATSU/Tradewind Blood Glucose Monitoring System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Ascensia Diabetes Care · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the performance and acceptability of a new blood glucose monitoring system, which includes meter and sensor strip.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Investigational Blood Glucose Monitoring System | Untrained subjects with diabetes performed Blood Glucose (BG) tests with subject's capillary fingerstick using the investigational Tradewind meter and investigational sensor. Study staff tested subject venous blood. All BG Results were compared to a reference laboratory glucose method. Subjects' success at performing basic tasks using only the User Guide were rated by study staff. |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-12-21
- Last updated
- 2016-02-29
- Results posted
- 2012-05-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01264016. Inclusion in this directory is not an endorsement.